A key Senate panel voted along party lines Tuesday afternoon to confirm Mehmet Oz as President Donald Trump’s (R) pick [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
President Donald Trump’s (R) pick of Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS) drew new [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The bipartisan group of six U.S. senators behind long-awaited 340B program overhaul legislation, known as the SUSTAIN 340B Act, is [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The manufacturers behind 15 drugs selected for the second round of Medicare drug price negotiations under the Inflation Reduction Act [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug pricing program is drawing newfound national media attention following recent articles on a multistate dark money ad [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...] …